Response to Kuvan® in Subjects With Phenylketonuria (PKU) in a 4 Weeks Testing Period
Clinical trial NCT01082328 · COMPLETED
Trial details
- NCT number
- NCT01082328
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2012-05-01
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.